| Literature DB >> 33578534 |
Kewei Li1, Fanwen Jiang2, Matthew Aizpuru3, Ellen L Larson3, Xiaolong Xie1, Rongxing Zhou4, Bo Xiang1.
Abstract
ABSTRACT: Optimal treatment of patients with various types of liver tumors or certain liver diseases frequently demands major liver resection, which remains a clinical challenge especially in children.Eighty seven consecutive pediatric liver resections including 51 (59%) major resections (resection of 3 or more hepatic segments) and 36 (41%) minor resections (resection of 1 or 2 segments) were analyzed. All patients were treated between January 2010 and March 2018. Perioperative outcomes were compared between major and minor hepatic resections.The male to female ratio was 1.72:1. The median age at operation was 20 months (range, 0.33-150 months). There was no significant difference in demographics including age, weight, ASA class, and underlying pathology. The surgical management included functional assessment of the future liver remnant, critical perioperative management, enhanced understanding of hepatic segmental anatomy, and bleeding control, as well as refined surgical techniques. The median estimated blood loss was 40 ml in the minor liver resection group, and 90 ml in major liver resection group (P < .001). Children undergoing major liver resection had a significantly longer median operative time (80 vs 140 minutes), anesthesia time (140 vs 205 minutes), as well as higher median intraoperative total fluid input (255 vs 450 ml) (P < .001 for all). Fourteen (16.1%) patients had postoperative complications. By Clavien-Dindo classification, there were 8 grade I, 4 grade II, and 2 grade III-a complications. There were no significant differences in complication rates between groups (P = .902). Time to clear liquid diet (P = .381) and general diet (P = .473) was not significantly different. There was no difference in hospital length of stay (7 vs 7 days, P = .450). There were no 90-day readmissions or mortalities.Major liver resection in children is not associated with an increased incidence of postoperative complications or prolonged postoperative hospital stay compared to minor liver resection. Techniques employed in this study offered good perioperative outcomes for children undergoing major liver resections.Entities:
Mesh:
Year: 2021 PMID: 33578534 PMCID: PMC7886405 DOI: 10.1097/MD.0000000000024420
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Future liver remnant (FLR) and total liver volume (TLV) estimation by CT volumetric analysis. A 20-month old boy, body weight (BW) 12.5 kg, diagnosed with mesenchymal hamartoma (MH). 1A and 1B display CT scan of the tumor. The arrow in 1A identifies the left hepatic vein. The arrow in 1B illustrates the inferior right hepatic vein. 1C displays the predicted FLR/BW ratio for trisegmentectomy (anatomic resection), estimated FLR/BW = 1.49%, estimated FLR/TLV = 15.11%. 1D demonstrates the predicted FLR/BW ratio for wedge resection (nonanatomic resection), estimated FLR/BW = 2.44%, estimated FLR/TLV = 24.70%. The arrow in 1E identifies the tumor. 1F displays liver remnant with adequate blood perfusion after wedge resection (preserving inferior right hepatic vein).
Figure 2Study flow of pediatric liver resections.
Preoperative and operative characteristics of patients undergoing hepatectomy according to surgical approach.
| Characteristic | Minor liver resection (n = 36) | Major liver resection (n = 51) | |
| Sex, n (%) | .312 | ||
| Male | 25 (28.7) | 30 (34.5) | |
| Female | 11 (12.6) | 21 (24.1) | |
| Age, month, median (range) | 12 (0.33-144) | 24 (1–150) | .168 |
| Weight, Kg, median (range) | 11.0 (3.7–50.0) | 13.2 (3.8–45.0) | .216 |
| ASA score > 2, n (%) | 21 (24.1) | 21 (24.1) | .115 |
| HBV-DNA, n (%) | 3 (3.4) | 1 (1.1) | .302 |
| Fibrosis, n (%) | 1 (1.1) | 3 (3.4) | .639 |
| NASH, n (%) | 0 | 0 | |
| SOS, n (%) | 0 | 0 | |
| Baseline liver function | |||
| Platelet count, × 10 9/dL, mean (SD) | 220.7 (72.1) | 252.7 (81.6) | .062 |
| INR, mean (SD) | 1.06 (0.06) | 1.04 (0.07) | .158 |
| Albumin, g/L, mean (SD) | 44.9 (4.4) | 44.4 (3.3) | .543 |
| TBIL, μmol/L, median (range) | 11.6 (5.3–30.8) | 11.9 (5.8–29.5) | .365 |
| ALBI grade, n (%) | .267 | ||
| 1 | 31 (35.6) | 48 (55.2) | |
| 2 | 5 (5.7) | 3 (3.4) | |
| Pathology, n (%) | .136 | ||
| Malignant disease | 15 (17.2) | 29 (33.3) | .195 |
| HBL | 10 (11.5) | 22 (25.3) | |
| PRETEXT I-II | 10 (11.5) | 11 (12.6) | |
| PRETEXT III | 0 | 11 (12.6) | |
| HCC | 2 (2.3) | 1 (1.1) | |
| other | 3 (3.4) | 6 (6.9) | |
| Benign disease | 21 (24.1) | 22 (25.3) | |
| hemangioendothelioma | 7 (8.0) | 5 (5.7) | |
| FNH | 3 (3.4) | 6 (6.9) | |
| MH | 3 (3.4) | 4 (4.6) | |
| AE | 1 (1.1) | 1 (1.1) | |
| Liver injury | 0 | 4 (4.6) | |
| other | 7 (8.0) | 2 (2.3) | |
AE = alveolar echinococcosis, FNH = focal nodular hyperplasia, HBL = hepatoblastoma, HCC = hepatocellular carcinoma, INR = international normalized ratio, MH = mesenchymal hamartoma, NASH = non-alcoholic fatty liver disease, SOS = sinusoidal obstruction syndrome, TBIL = total bilirubin.
Intraoperative characteristics of patients undergoing hepatectomy according to surgical approach.
| Characteristic | Minor liver resection (n = 36) | Major liver resection (n = 51) | |
| Type of liver resection, n (%) | |||
| Right hepatectomy | 0 | 18 (20.7) | |
| Left hepatectomy | 0 | 8 (9.2) | |
| Central resection | 0 | 5 (5.7) | |
| Caudate lobe resection | 5 (5.7) | 0 | |
| Extended right hepatectomy | 0 | 6 (6.9) | |
| Extended left hepatectomy | 0 | 2 (2.3) | |
| Trisegmentectomy | 0 | 5 (5.7) | |
| other | 31 (35.6) | 7 (8.0) | |
| Biliary reconstruction, n (%) | 0 | 6 (6.9) | .040 |
| Vascular reconstruction, n (%) | 1 (1.1) | 9 (10.3) | .041 |
| Diaphragm resection, n (%) | 0 | 2 (2.3) | .509 |
| No. of resected segments, n (%) | |||
| 1 | 11 (12.6) | 0 | |
| 2 | 25 (28.7) | 0 | |
| 3 | 0 | 8 (9.2) | |
| 4 | 0 | 23 (26.4) | |
| ≥5 | 0 | 20 (23.0) | |
| Surgical margin R1/R2, n (%) | 0 | 0 | |
| Pringle maneuver, n (%) | 0 | 18 (20.7) | <.001 |
| Hemihepatic vascular occlusion, n (%) | 6 (6.9) | 26 (29.9) | .001 |
| Segmental vascular occlusion, n (%) | 6 (6.9) | 0 | .004 |
| THVE, n (%) | 1 (1.1) | 0 | .414 |
| Operation time, min, median (range) | 80 (40–170) | 140 (90–230) | <.001 |
| Anesthesia time, min, median (range) | 140 (100–240) | 205 (160–300) | <.001 |
| Total fluid input, ml, median (range) | 255 (100–700) | 450 (200–1300) | <.001 |
| Total Urine output, ml, median (range) | 70 (30–300) | 130 (40–390) | <.001 |
| Estimated blood loss, ml, median (range) | 40 (15–200) | 90 (30–400) | <.001 |
| Transfusion rate, n (%) | 6 (6.9) | 20 (23.0) | .024 |
THVE = total hepatic vascular exclusion.
Figure 3Complete caudate lobectomy (right- and left-sided approaches) for large focal nodular hyperplasia (FNH) with 20 minutes of total hepatic vascular exclusion (THVE). The arrow in 3A identifies a large FNH with extensively caudate lobe invasion. 3B displays the resected tumor. The arrows in 3C show the space between liver, hepatoduodenal ligament and vena cava after tumor had been removed. 3D shows the THVE technique used in this patient.
Comparison of postoperative complications and recovery course of patients undergoing hepatectomy according to surgical approach.
| Characteristic | Minor liver resection (n = 36) | Major liver resection (n = 51) | |
| Clavien-Dindo grade, n (%) | 6 (6.9) | 8 (9.2) | .902 |
| I | 2 (2.3) | 6 (6.9) | .461 |
| II | 3 (3.4) | 1 (1.1) | .302 |
| III-a | 1 (1.1) | 1 (1.1) | 1.000 |
| III-b/IV-a, b/V | 0 | 0 | |
| Haemorrhage, n (%) | 0 | 0 | |
| Ascites, n (%) | 1 (1.1) | 2 (2.3) | |
| PHLF, n (%) | 0 | 0 | |
| Confusion, n (%) | 0 | 0 | |
| The 50–50 criteria, n (%) | 0 | 0 | |
| Biliary leakage, n (%) | 0 | 3 (3.4) | |
| SSI, n (%) | 1 (1.1) | 0 | |
| Respiratory infections, n (%) | 3 (3.4) | 1 (1.1) | |
| Pleural effusion, n (%) | 1 (1.1) | 2 (2.3) | |
| Renal failure, n (%) | 0 | 0 | |
| Reoperation, n (%) | 0 | 0 | |
| Time to clear liquid diet, d, median (range) | 3 (1–3) | 3 (1–4) | .381 |
| Time to general diet, d, median (range) | 3 (1–4) | 3 (2–5) | .473 |
| MS equiv. used, mg/kg, mean (SD) | 1.05 (0.10) | 1.11 (0.12) | .03 |
| ICU stay, hour, mean (SD) | 23 (0–70) | 40 (19–80) | <.001 |
| Postoperative hospital stay, d, mean (SD) | 7 (4–15) | 7 (4–12) | .450 |
| Readmission within 90 days, n (%) | 0 | 0 | |
| Postoperative mortality, n (%) | 0 | 0 |
PHLF = posthepatectomy liver failure, SSI = surgical site infection, PPCs = postoperative pulmonary complications, MS equiv = morphine sulphate equivalents, ICU = intensive care unit.